Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cardiome Reports Second Quarter Results
Yahoo
Monday, August 8, 2011 - 9:17am
tags:
earnings, Cardiome
Teva Receives FDA Acceptance of Its New Drug Application for BDP Nasal HFA for the Treatment of Allergic Rhinitis
Yahoo
Monday, August 8, 2011 - 9:14am
tags:
Teva Pharmaceuticals, FDA, BDP Nasal HFA, allergic rhinitis
Valeant Pharma Beats, Ups View
Yahoo/Zacks.com
Monday, August 8, 2011 - 9:11am
tags:
earnings, Valeant Pharmaceuticals
What is Teva really worth?
Globes, Israel
Sunday, August 7, 2011 - 11:44am
tags:
Teva Pharmaceuticals
Dr Reddy's expects North American biz to drive growth this FY
Economic Times, India
Sunday, August 7, 2011 - 11:43am
tags:
Dr Reddy's
Generic drug industry slams special deal in patent reform bill
The Hill
Sunday, August 7, 2011 - 11:41am
tags:
generics
India's Aurobindo Pharma posts 1Q loss
MarketWatch
Saturday, August 6, 2011 - 1:56pm
tags:
Aurobindo, earnings
Qiagen Completes Second U.S. Submission For Companion Diagnostic To Guide Treatment Decisions In Colorectal Cancer
Biomed Reports
Saturday, August 6, 2011 - 1:53pm
tags:
Qiagen, KRAS assay, Erbitux, colorectal cancer
HHS-OIG Drops Potential Action against Forest CEO Howard Solomon
MarketWatch
Saturday, August 6, 2011 - 1:51pm
tags:
OIG, investigations, legal, Forest Labs
Enzon Inc. Reports Operating Results (10-Q)
GuruFocus
Saturday, August 6, 2011 - 1:29pm
tags:
Enzon, earnings
U.K. rejects MS drug over cost
Yahoo/Investor's Business Daily
Saturday, August 6, 2011 - 1:26pm
tags:
Novartis, multiple sclerosis, Gilenya
Novo Nordisk Revenues Up
Yahoo/Zacks
Saturday, August 6, 2011 - 1:25pm
tags:
Novo Nordisk, earnings
Lower Spending Boosts Par Pharma
Yahoo/Zacks
Saturday, August 6, 2011 - 1:24pm
tags:
Par Pharmaceutical
Big Pharma: M&A Spells Disaster for R&D
Seeking Alpha
Saturday, August 6, 2011 - 1:23pm
tags:
M&A, R&D
Momenta's earnings rise on market grab from Sanofi
bizjournals
Saturday, August 6, 2011 - 1:22pm
tags:
Momenta, Lovenox, Sanofi, generics
Surviving the Biotech Selloff (video)
The Street
Saturday, August 6, 2011 - 1:08pm
tags:
Sequenom's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 6, 2011 - 1:04pm
tags:
Sequenom, earnings
Halozyme Therapeutics Shares Popped: What You Need to Know
Motley Fool
Saturday, August 6, 2011 - 1:04pm
tags:
Halozyme, ViroPharma, Baxter International, rHuPH20
Loss at MannKind Wider than Expected
Yahoo/Zacks
Saturday, August 6, 2011 - 1:02pm
tags:
MannKind, earnings
Still Want to Be the Next Dendreon?
Motley Fool
Saturday, August 6, 2011 - 1:01pm
tags:
Dendreon, Vertex Pharmaceuticals, Incivek, hepatitis B

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.